Position in BMY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$741,396
+$187,965 QoQ
Shares Held
12,867
+41.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,320
of 2,506 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monument Capital Management holds $17,122,223 across 11 Drug Manufacturers - General names. BMY ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,097 | $4,596,095 | |
| 2 | LLY |
ELI LILLY & Co
|
2,528 | $3,032,159 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,665 | $2,912,452 | |
| 4 | ABBV |
AbbVie Inc.
|
6,503 | $1,636,414 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,267 | $1,549,812 | |
| 6 | AMGN |
Amgen Inc
|
2,614 | $946,581 | |
| 7 | NVS |
Novartis AG
|
5,076 | $795,510 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
12,867 | $741,396 |
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $741,396 | 12,867 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $553,431 | 9,125 | Shares | Sole | 2026-04-16 | |
| 2024-12-31 | $206,726 | 3,655 | Shares | Sole | 2025-01-31 | |
| 2023-03-31 | $385,848 | 5,567 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $477,676 | 6,639 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $327,582 | 4,608 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $444,290 | 5,770 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $255,166 | 3,494 | Shares | Sole | 2022-04-14 | |
| 2021-06-30 | $212,353 | 3,178 | Shares | Sole | 2021-07-27 | |
| No filing history on record for this holder in this stock. | ||||||